Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. has announced that Kenneth C. Frazier, Chairman and Chief Executive Officer (CEO), will retire as CEO, effective June 30, 2021. Robert M. Davis, Merck’s current Executive Vice President, Global Services, and Chief Financial Officer,...

As part of ongoing divestment program of non-core assets following its $62-billion acquisition of Shire in 2019, Takeda Pharmaceutical has completed two separate deals to divest non-core assets totaling a combined $1.25 billion. Deal with Hypera...

The latest on manufacturing, potential treatments, and testing for COVID-19 with news from J&J, Moderna, Novavax, GSK, CSL, Lilly, Roche, and others. Manufacturing and supply of COVID-19 vaccines and drugs Moderna Increases Supply of COVID-19...

Pfizer and BioNTech plan to increase manufacturing of their COVID-19 vaccine in 2021 from 1.3 billion doses to 2 billion doses on a global basis and formed an initial manufacturing pact with Novartis. To enable the increase in manufacturing, the...